Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.19.3
Shareholders' Deficit (Tables)
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]
Schedule of nonvested activity

Number of

Non-vested Shares

 Weighted Average Grant Date Fair Value
Non-vested, December 31, 2018 5,998,672 $ 0.61
Granted 10,700,000 0.05
Shares vested (323,373 ) (0.85 )
Forfeited - -
Non-vested, September 30, 2019 16,375,299 $ 0.24
Schedule of stock option activities
Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic
Value
Balance Outstanding, December 31, 2018 11,445,698 $ 0.30
Granted - -
Exercised - -
Forfeited - -
Balance Outstanding, September 30, 2019 11,445,698 $ 0.30 5.86 $ 50,400
Exercisable, September 30, 2019 10,401,862 $ 0.30 5.64 $ 50,400
Schedule of warrant activities
Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic
Value
Balance Outstanding December 31, 2018 - $ - - $ -
Granted 1,750,000 0.09
Cancelled - -
Balance Outstanding September 30, 2019 1,750,000 $ 0.09 4.84 $ 0
Exercisable, September 30, 2019 1,750,000 $ 0.09 4.84 $ 0